Also, restoring wild-type TP53 transcriptional activity, or at least tipping the balance away from oncogenic mutant isoforms, has been receiving attention as a means to tackle melanoma cell proliferation and therapy resistance (54). The gene discussed is TP53; the disease is melanoma.